The disaccharide moiety of bleomycin facilitates uptake by cancer cells

Benjamin R. Schroeder, M. Imran Ghare, Chandrabali Bhattacharya, Rakesh Paul, Zhiqiang Yu, Paul A. Zaleski, Trevor C. Bozeman, Michael J. Rishel, Sidney Hecht

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

The disaccharide moiety is responsible for the tumor cell targeting properties of bleomycin (BLM). While the aglycon (deglycobleomycin) mediates DNA cleavage in much the same fashion as bleomycin, it exhibits diminished cytotoxicity in comparison to BLM. These findings suggested that BLM might be modular in nature, composed of tumor-seeking and tumoricidal domains. To explore this possibility, BLM analogues were prepared in which the disaccharide moiety was attached to deglycobleomycin at novel positions, namely, via the threonine moiety or C-terminal substituent. The analogues were compared with BLM and deglycoBLM for DNA cleavage, cancer cell uptake, and cytotoxic activity. BLM is more potent than deglycoBLM in supercoiled plasmid DNA relaxation, while the analogue having the disaccharide on threonine was less active than deglycoBLM and the analogue containing the C-terminal disaccharide was slightly more potent. While having unexceptional DNA cleavage potencies, both glycosylated analogues were more cytotoxic to cultured DU145 prostate cancer cells than deglycoBLM. Dye-labeled conjugates of the cytotoxic BLM aglycons were used in imaging experiments to determine the extent of cell uptake. The rank order of internalization efficiencies was the same as their order of cytotoxicities toward DU145 cells. These findings establish a role for the BLM disaccharide in tumor targeting/uptake and suggest that the disaccharide moiety may be capable of delivering other cytotoxins to cancer cells. While the mechanism responsible for uptake of the BLM disaccharide selectively by tumor cells has not yet been established, data are presented which suggest that the metabolic shift to glycolysis in cancer cells may provide the vehicle for selective internalization.

Original languageEnglish (US)
Pages (from-to)13641-13656
Number of pages16
JournalJournal of the American Chemical Society
Volume136
Issue number39
DOIs
StatePublished - Oct 1 2014

Fingerprint

Disaccharides
Bleomycin
Cells
Tumors
DNA
Neoplasms
DNA Cleavage
Cytotoxicity
Threonine
Superhelical DNA
Cytotoxins
Glycolysis
Dyes
Imaging techniques
Prostatic Neoplasms
Plasmids
Coloring Agents

ASJC Scopus subject areas

  • Chemistry(all)
  • Catalysis
  • Biochemistry
  • Colloid and Surface Chemistry

Cite this

Schroeder, B. R., Ghare, M. I., Bhattacharya, C., Paul, R., Yu, Z., Zaleski, P. A., ... Hecht, S. (2014). The disaccharide moiety of bleomycin facilitates uptake by cancer cells. Journal of the American Chemical Society, 136(39), 13641-13656. https://doi.org/10.1021/ja507255g

The disaccharide moiety of bleomycin facilitates uptake by cancer cells. / Schroeder, Benjamin R.; Ghare, M. Imran; Bhattacharya, Chandrabali; Paul, Rakesh; Yu, Zhiqiang; Zaleski, Paul A.; Bozeman, Trevor C.; Rishel, Michael J.; Hecht, Sidney.

In: Journal of the American Chemical Society, Vol. 136, No. 39, 01.10.2014, p. 13641-13656.

Research output: Contribution to journalArticle

Schroeder, BR, Ghare, MI, Bhattacharya, C, Paul, R, Yu, Z, Zaleski, PA, Bozeman, TC, Rishel, MJ & Hecht, S 2014, 'The disaccharide moiety of bleomycin facilitates uptake by cancer cells', Journal of the American Chemical Society, vol. 136, no. 39, pp. 13641-13656. https://doi.org/10.1021/ja507255g
Schroeder BR, Ghare MI, Bhattacharya C, Paul R, Yu Z, Zaleski PA et al. The disaccharide moiety of bleomycin facilitates uptake by cancer cells. Journal of the American Chemical Society. 2014 Oct 1;136(39):13641-13656. https://doi.org/10.1021/ja507255g
Schroeder, Benjamin R. ; Ghare, M. Imran ; Bhattacharya, Chandrabali ; Paul, Rakesh ; Yu, Zhiqiang ; Zaleski, Paul A. ; Bozeman, Trevor C. ; Rishel, Michael J. ; Hecht, Sidney. / The disaccharide moiety of bleomycin facilitates uptake by cancer cells. In: Journal of the American Chemical Society. 2014 ; Vol. 136, No. 39. pp. 13641-13656.
@article{844999ca737649dfb720b985d139d6ac,
title = "The disaccharide moiety of bleomycin facilitates uptake by cancer cells",
abstract = "The disaccharide moiety is responsible for the tumor cell targeting properties of bleomycin (BLM). While the aglycon (deglycobleomycin) mediates DNA cleavage in much the same fashion as bleomycin, it exhibits diminished cytotoxicity in comparison to BLM. These findings suggested that BLM might be modular in nature, composed of tumor-seeking and tumoricidal domains. To explore this possibility, BLM analogues were prepared in which the disaccharide moiety was attached to deglycobleomycin at novel positions, namely, via the threonine moiety or C-terminal substituent. The analogues were compared with BLM and deglycoBLM for DNA cleavage, cancer cell uptake, and cytotoxic activity. BLM is more potent than deglycoBLM in supercoiled plasmid DNA relaxation, while the analogue having the disaccharide on threonine was less active than deglycoBLM and the analogue containing the C-terminal disaccharide was slightly more potent. While having unexceptional DNA cleavage potencies, both glycosylated analogues were more cytotoxic to cultured DU145 prostate cancer cells than deglycoBLM. Dye-labeled conjugates of the cytotoxic BLM aglycons were used in imaging experiments to determine the extent of cell uptake. The rank order of internalization efficiencies was the same as their order of cytotoxicities toward DU145 cells. These findings establish a role for the BLM disaccharide in tumor targeting/uptake and suggest that the disaccharide moiety may be capable of delivering other cytotoxins to cancer cells. While the mechanism responsible for uptake of the BLM disaccharide selectively by tumor cells has not yet been established, data are presented which suggest that the metabolic shift to glycolysis in cancer cells may provide the vehicle for selective internalization.",
author = "Schroeder, {Benjamin R.} and Ghare, {M. Imran} and Chandrabali Bhattacharya and Rakesh Paul and Zhiqiang Yu and Zaleski, {Paul A.} and Bozeman, {Trevor C.} and Rishel, {Michael J.} and Sidney Hecht",
year = "2014",
month = "10",
day = "1",
doi = "10.1021/ja507255g",
language = "English (US)",
volume = "136",
pages = "13641--13656",
journal = "Journal of the American Chemical Society",
issn = "0002-7863",
publisher = "American Chemical Society",
number = "39",

}

TY - JOUR

T1 - The disaccharide moiety of bleomycin facilitates uptake by cancer cells

AU - Schroeder, Benjamin R.

AU - Ghare, M. Imran

AU - Bhattacharya, Chandrabali

AU - Paul, Rakesh

AU - Yu, Zhiqiang

AU - Zaleski, Paul A.

AU - Bozeman, Trevor C.

AU - Rishel, Michael J.

AU - Hecht, Sidney

PY - 2014/10/1

Y1 - 2014/10/1

N2 - The disaccharide moiety is responsible for the tumor cell targeting properties of bleomycin (BLM). While the aglycon (deglycobleomycin) mediates DNA cleavage in much the same fashion as bleomycin, it exhibits diminished cytotoxicity in comparison to BLM. These findings suggested that BLM might be modular in nature, composed of tumor-seeking and tumoricidal domains. To explore this possibility, BLM analogues were prepared in which the disaccharide moiety was attached to deglycobleomycin at novel positions, namely, via the threonine moiety or C-terminal substituent. The analogues were compared with BLM and deglycoBLM for DNA cleavage, cancer cell uptake, and cytotoxic activity. BLM is more potent than deglycoBLM in supercoiled plasmid DNA relaxation, while the analogue having the disaccharide on threonine was less active than deglycoBLM and the analogue containing the C-terminal disaccharide was slightly more potent. While having unexceptional DNA cleavage potencies, both glycosylated analogues were more cytotoxic to cultured DU145 prostate cancer cells than deglycoBLM. Dye-labeled conjugates of the cytotoxic BLM aglycons were used in imaging experiments to determine the extent of cell uptake. The rank order of internalization efficiencies was the same as their order of cytotoxicities toward DU145 cells. These findings establish a role for the BLM disaccharide in tumor targeting/uptake and suggest that the disaccharide moiety may be capable of delivering other cytotoxins to cancer cells. While the mechanism responsible for uptake of the BLM disaccharide selectively by tumor cells has not yet been established, data are presented which suggest that the metabolic shift to glycolysis in cancer cells may provide the vehicle for selective internalization.

AB - The disaccharide moiety is responsible for the tumor cell targeting properties of bleomycin (BLM). While the aglycon (deglycobleomycin) mediates DNA cleavage in much the same fashion as bleomycin, it exhibits diminished cytotoxicity in comparison to BLM. These findings suggested that BLM might be modular in nature, composed of tumor-seeking and tumoricidal domains. To explore this possibility, BLM analogues were prepared in which the disaccharide moiety was attached to deglycobleomycin at novel positions, namely, via the threonine moiety or C-terminal substituent. The analogues were compared with BLM and deglycoBLM for DNA cleavage, cancer cell uptake, and cytotoxic activity. BLM is more potent than deglycoBLM in supercoiled plasmid DNA relaxation, while the analogue having the disaccharide on threonine was less active than deglycoBLM and the analogue containing the C-terminal disaccharide was slightly more potent. While having unexceptional DNA cleavage potencies, both glycosylated analogues were more cytotoxic to cultured DU145 prostate cancer cells than deglycoBLM. Dye-labeled conjugates of the cytotoxic BLM aglycons were used in imaging experiments to determine the extent of cell uptake. The rank order of internalization efficiencies was the same as their order of cytotoxicities toward DU145 cells. These findings establish a role for the BLM disaccharide in tumor targeting/uptake and suggest that the disaccharide moiety may be capable of delivering other cytotoxins to cancer cells. While the mechanism responsible for uptake of the BLM disaccharide selectively by tumor cells has not yet been established, data are presented which suggest that the metabolic shift to glycolysis in cancer cells may provide the vehicle for selective internalization.

UR - http://www.scopus.com/inward/record.url?scp=84907482081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907482081&partnerID=8YFLogxK

U2 - 10.1021/ja507255g

DO - 10.1021/ja507255g

M3 - Article

C2 - 25184545

AN - SCOPUS:84907482081

VL - 136

SP - 13641

EP - 13656

JO - Journal of the American Chemical Society

JF - Journal of the American Chemical Society

SN - 0002-7863

IS - 39

ER -